EP Patent

EP0276370A2 — Verwendung niedermolekularer Dextransulfate als Arteriosklerosemittel

Assigned to Abbott GmbH and Co KG · Expires 1988-08-03 · 38y expired

What this patent protects

Es wird die Verwendung von niedermolekularem Dextransulfat bei der Bekämpfung von Arteriosklerose beschrieben.

USPTO Abstract

Es wird die Verwendung von niedermolekularem Dextransulfat bei der Bekämpfung von Arteriosklerose beschrieben.

Drugs covered by this patent

Patent Metadata

Patent number
EP0276370A2
Jurisdiction
EP
Classification
—
Expires
1988-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Abbott GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.